CJC-1295 (no-DAC)
Source / Derivation:
​​​
CJC-1295 no-DAC is a synthetic growth hormone–releasing hormone (GHRH) analog engineered for short-duration, physiologic GH stimulation. It is derived from modifications to the native GHRH sequence that enhance stability while maintaining natural pulse patterns.
.png)
CJC-1295 (no-DAC)
Mechanism of Action:
​​
CJC-1295 no-DAC binds to GHRH receptors in the anterior pituitary, promoting endogenous GH release in alignment with the body’s natural pulsatile rhythm. This supports downstream IGF-1 production, improved cellular repair, lipid metabolism, sleep quality, and overall anabolic balance.​
​
Clinical Relevance & Potential Outcomes:
​
Research indicates that CJC-no-DAC may support improved recovery, lean muscle development, metabolic efficiency, and more restorative sleep architecture. It is widely utilized for enhancing physiologic GH output without prolonged systemic exposure.
​
Intended Clinical Application:
​
CJC-no-DAC may be appropriate for patients requiring support with recovery, metabolic function, tissue repair, or optimization of natural growth hormone signaling.
Concentration:
​
Frequency:
​
Dosage (pen clicks):
​
Duration:
​
Notes:
10 mg/ml, total 3 ml, total 30 mg
​​
Daily​
​
10​
​
1 month​
​
A growth hormone-releasing hormone (GHRH) analog that stimulates natural growth hormone secretion for muscle growth, fat loss, and anti-aging benefits​.